Against pandemic research exceptionalism

@article{London2020AgainstPR,
  title={Against pandemic research exceptionalism},
  author={Alex John London and Jonathan Kimmelman},
  journal={Science},
  year={2020},
  volume={368},
  pages={476 - 477}
}
Crises are no excuse for lowering scientific standards The global outbreak of coronavirus disease 2019 (COVID-19) has seen a deluge of clinical studies, with hundreds registered on clinicaltrials.gov. But a palpable sense of urgency and a lingering concern that “in critical situations, large randomized controlled trials are not always feasible or ethical” (1) perpetuate the perception that, when it comes to the rigors of science, crisis situations demand exceptions to high standards for quality… Expand
Professional Commitment to Ethical Discussions Needed From Epidemiologists in the COVID-19 Pandemic
TLDR
Engagement in ethical issues on COVID-19 is minimal at best, and the extent to which scholarly journals of epidemiology have served as discussion forums for ethical issues has become unclear, even though many of the ethical questions noted above would likely be important for epidemiologists as well. Expand
Ethical conditions for accelerating COVID-19 vaccine research
There is a dire need to produce a safe and effective coronavirus disease 2019 (COVID-19) vaccine as quickly as possible to avert an enormous burden of morbidity and mortality. This need for speed hasExpand
Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?
Abstract After witnessing extraordinary scientific and regulatory efforts to speed development of and access to new COVID-19 interventions, patients facing other serious diseases have begun to askExpand
Ethical Challenges in Clinical Research During the COVID-19 Pandemic
TLDR
The ethical challenges in decision-making and competing ethical tensions during the COVID-19 pandemic are discussed in an effort to advance future preparedness. Expand
COVID-19 Pandemic and Research Publications; Necessity of Maintaining Scientific Integrity
Since the COVID-19 outbreak began in China, scientists and health professionals have rushed to understand and mitigate the threat, however, its root cause, spreading characteristic, effective way toExpand
Obstacles and Considerations Related to Clinical Trial Research During the COVID-19 Pandemic
TLDR
The response to the COVID-19 pandemic from the research and science community has been vigorous, with information being released faster than that of any other event in human history, but research efforts should maintain the same high-quality core ethical principles that governed human subject research before the pandemic. Expand
Are SARS-CoV-2 Human Challenge Trials Ethical?
TLDR
A clinical trial is underway in the UK in which young, healthy participants are exposed deliberately to SARS-CoV-2 to assess the viral inoculum needed to produce an infection and to test vaccine efficacy, and how the UK COVID-19 challenge trial measures up against ethical criteria is examined. Expand
SARS-CoV-2 challenge studies: ethics and risk minimisation
COVID-19 poses an exceptional threat to global public health and well-being. Recognition of the need to develop effective vaccines at unprecedented speed has led to calls to accelerate researchExpand
So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development
TLDR
Ethical analysis suggests that accelerated RCTs are the best approach to accelerating vaccine development in a pandemic, and more likely than other approaches to enhance social value without compromising ethics or science. Expand
Collaborative Platform Trials to Fight COVID‐19: Methodological and Regulatory Considerations for a Better Societal Outcome
TLDR
Several possible designs for collaborative evidence‐generation initiatives are discussed, such as the heterogeneity of the target population, time‐varying standard of care, and the potentially high number of false hypothesis rejections in phase II and phase III trials are discussed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 28 REFERENCES
Social Value, Clinical Equipoise, and Research in a Public Health Emergency
TLDR
It is defended against two lines of criticism that emerged during the 2014 Ebola outbreak that held that desperately ill patients have a moral right to try unvalidated medical interventions and that it is therefore unethical to restrict access to UMIs to the clinical trial context. Expand
Clinical Trial Portfolios: A Critical Oversight in Human Research Ethics, Drug Regulation, and Policy.
TLDR
It is demonstrated that explicit consideration of trial portfolios-series of trials that are interrelated by a common set of objectives-is crucial for addressing the ethical and scientific questions that arise in clinical trials. Expand
Harms From Uninformative Clinical Trials.
TLDR
Clinical trials are designed, conducted, and reported in ways that stymie this objective, a problem that can be called “uninformativeness,” which is a form of research inefficiency. Expand
A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups
TLDR
A meta-analysis of six clinical studies conducted during the West Africa Ebola virus disease outbreak revealed considerable heterogeneity in the different control groups, suggesting that nonrandomized control group data cannot be used as a comparator for experimental treatments in future clinical studies lacking a randomized control group. Expand
When clinical trials compete: prioritising study recruitment
TLDR
It is argued that an institutional policy that prioritises some trials for recruitment ahead of others is ethically permissible and indeed prima facie preferable to alternative means of addressing recruitment competition. Expand
Can a century-old TB vaccine steel the immune system against the new coronavirus?
Researchers in four countries will soon start a clinical trial of an unorthodox approach to the new coronavirus They will test whether a century-old vaccine against tuberculosis (TB), a bacterialExpand
Adaptive platform trials: definition, design, conduct and reporting considerations
TLDR
Common features and issues that arise with adaptive platform trials, which can study multiple therapeutic interventions in a disease in a perpetual manner, are reviewed and recommendations to improve the efficiency of drug development are put forward. Expand
Adaptive platform trials: definition, design, conduct and reporting considerations
Researchers, clinicians, policymakers and patients are increasingly interested in questions about therapeutic interventions that are difficult or costly to answer with traditional, free-standing,Expand
Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans.
TLDR
The aim of the guidelines is to provide internationally vetted ethical principles and detailed commentary on how these principles should be applied, with particular attention to conducting research in lowand middleincome countries (LMICs). Expand
Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.
Responding to Global Infectious Disease Outbreaks As in the ongoing Covid-19 pandemic, global outbreaks of infectious illnesses often develop quickly and resolve in unpredictable ways. In this repo...
...
1
2
3
...